Skip to content
healthcare.dev
Get a free key

Xarelto

NDC 50458-575, rivaroxaban, granule, for suspension, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-575
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
GRANULE, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215859
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-575 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN155 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
50458-575-01504580575011 BOTTLE in 1 CARTON (50458-575-01) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/10db92f9-2300-4a80-836b-673e1ae91610

  • NADAC price for package 50458057501

    GET /v1/drugs/nadac/50458057501

Use it

Look up 50458-575 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-575 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-575. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.